Loading
Enovix Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Talluri Rajendra K, was filed 25 Aug 2023.
Enovix Corp: what insiders have been doing
Enovix Corp is a Chemicals & Materials company based in United States. Its directors and officers file their transactions with SEC (Form 4). In the past year (22 October 2025 to 22 October 2026), 153 filings came from 13 insiders.
Only sales appear on the open market, 1 sale in all totalling €14k, filed by 1 insider. One trade stands out by size: a sale of €14k from Truong Kristina, disclosed on 5 January 2026.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Compared with its exchange (3,171 companies, median 24 filings), a count of 153 filings is above the norm. Over the whole record (from 2020), the tally stands at 24 purchases and 37 sales. For the fiscal year to 28 December 2025, the annual 10-K puts revenue at 31.8 m USD and net income at -156.7 m USD.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
646
Thresholds
n/a
Buy Volume
€35M
24 ops. · all time
Sell Volume
€10M
37 ops. · all time
Who traded when
BuySaleAjay Marathe2 sales
Betsy S. Atkins1 sale
Gregory Reichow1 sale
Kristina Truong1 sale
Rajendra K. Talluri1 sale
Since the insiders bought
- -25.5%Entry US$14.00 · Close at T+365 US$10.43
- -28.5%Entry US$11.50 · Close at T+365 US$8.22
- +38.8%Entry US$9.05 · Close at T+365 US$12.56
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Enovix Corp Buy (bullish), based on 10 analysts. Average price target: US$9.75.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 25,445 of 26,246 companies
12.2
score / 100
Value9
Quality15
FCF yld-20%
Earn yld-28%
EV/EBITDA·
ROE-81%
Gross mgn19%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$2.54
Analyst consensus
10 analystsBuy
US$5.00Target US$9.75(+284%)US$21.00
Income statement
RevenueUS$31.8M
Gross profitUS$6.1M19% margin
EBITDA-US$101.2M-318% margin
Net income-US$156.7M-492.6% margin
Valuation
PER (forward)-4.1x
P/Book2.6x
Beta2.48
Balance sheet & cash
Market capUS$557.4M
Total debtUS$540.4M
Free Cash Flow-US$113.5M
Debt / Equity256%
Profitability & ownership
ROE-81.3%
ROA-17.6%
% insiders11.7%
% institutions51.9%
Last declaration on 16 October 2026
Declarations646 total
19,823 shares@ US$2.440.0090% mcap6.0% of flowCommon StockSEC:0001564606-26-000017:0
1,015 shares@ US$2.510.0005% mcap0.6% of flowCommon StockSEC:0002052363-26-000063:0
253 shares@ US$2.460.0001% mcap0.1% of flowCommon StockSEC:0002052363-26-000061:1
936 shares@ US$2.500.0004% mcap0.1% of flowCommon StockSEC:0001975015-26-000058:0
3,359 shares@ US$2.500.0015% mcap0.4% of flowCommon StockSEC:0001975015-26-000058:1
1,680 shares@ US$2.500.0007% mcap1.0% of flowCommon StockSEC:0002052363-26-000061:0
638 shares@ US$2.670.0003% mcap0.4% of flowCommon StockSEC:0002052363-26-000059:0
7,032 shares@ US$2.780.0032% mcap1.0% of flowCommon StockSEC:0001975015-26-000056:1
10,988 shares@ US$2.780.0049% mcap4.0% of flowCommon StockSEC:0001564606-26-000015:0
2,225 shares@ US$2.780.0010% mcap1.5% of flowCommon StockSEC:0002052363-26-000056:0
4,395 shares@ US$2.780.0020% mcap2.9% of flowCommon StockSEC:0002052363-26-000056:1
3,336 shares@ US$2.780.0015% mcap0.5% of flowCommon StockSEC:0001975015-26-000056:0
2,221 shares@ US$2.960.0010% mcap0.3% of flowCommon StockSEC:0001975015-26-000054:0
253 shares@ US$3.140.0001% mcap0.2% of flowCommon StockSEC:0002052363-26-000054:0
1,014 shares@ US$3.100.0006% mcap0.7% of flowCommon StockSEC:0002052363-26-000054:1
936 shares@ US$3.470.0006% mcap0.1% of flowCommon StockSEC:0001975015-26-000052:0
19,060 shares0Common StockSEC:0001564606-26-000013:0
10,093 shares@ US$3.360.0051% mcap4.5% of flowCommon StockSEC:0001564606-26-000013:1
18,546 shares0Common StockSEC:0001975015-26-000049:0
9,821 shares@ US$3.360.0050% mcap1.7% of flowCommon StockSEC:0001975015-26-000049:1
12,512 shares0Common StockSEC:0002052363-26-000052:0
6,626 shares@ US$3.360.0034% mcap5.3% of flowCommon StockSEC:0002052363-26-000052:1
2,221 shares@ US$3.270.0011% mcap0.4% of flowCommon StockSEC:0001975015-26-000048:0
1,015 shares@ US$4.430.0007% mcap1.1% of flowCommon StockSEC:0002052363-26-000050:0
4,300 shares@ US$4.700.0031% mcap0.2% of flowCommon StockSEC:0001961877-26-000043:0
25 of 646 declarations
About Enovix Corp
Enovix Corp. (Nasdaq: ENVX) is a U.S.-based next-generation battery company focused on silicon-anode lithium-ion cells and proprietary architectures designed to deliver higher energy density without compromising safety. Headquartered in Fremont, California, United States, the company was founded in the mid-2000s by its co-founders around a clear mission: to materially improve battery performance for mobile devices, connected electronics, and, longer term, other high-energy-use applications. Enovix went public through a SPAC merger in 2021 and is now listed on the Nasdaq, making it a growth-oriented equity with meaningful exposure to technology adoption cycles and manufacturing execution.
The company’s core business is the design, industrialization, and commercialization of advanced batteries. Its platform is built around a proprietary silicon-anode architecture, often described by Enovix as a 3D battery structure, intended to increase energy capacity within compact device form factors. Enovix targets applications including smartphones, wearables, mobile computing, smart devices, and emerging AI-enabled consumer products. The company also markets battery products for smart eyewear and other devices that require high energy density in a small footprint.
Read moreShow less
From a competitive standpoint, Enovix operates in a market dominated by large Asian lithium-ion battery manufacturers and a smaller group of advanced-materials innovators. Its positioning is that of a niche technology disruptor rather than a mass-market commodity supplier. The investment case is based on performance differentiation, safety, and miniaturization, which can support premium OEM relationships and design wins. At the same time, this model carries execution risk: scaling manufacturing, converting customer interest into volume shipments, and maintaining financial discipline remain critical.
Geographically, Enovix keeps its headquarters in the United States while operating manufacturing and/or operational facilities in Malaysia and South Korea, according to recent company disclosures. Recent developments have been important for the equity story: in 2025 and 2026, Enovix highlighted the launch of its AI-1 smartphone battery platform, began commercial production of silicon-anode smart eyewear batteries, and signaled progress toward mass production. It also added commercial leadership to support scale-up and revenue growth. For French-speaking investors, Enovix should be viewed as a high-growth technology materials company with differentiated battery IP, but one that remains highly dependent on commercialization milestones, ramp execution, and customer adoption.
